Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Nello Mainolfi

Nello Mainolfi is recorded as CEO and Board Member at Kymera Therapeutics, Inc. (KYMR). The proxy statement of Kymera Therapeutics, Inc. reports total compensation of $8,545,609 for Nello Mainolfi in fiscal 2025, including a base salary of $693,000. Disclosed compensation is on record for 6 fiscal years. Nello Mainolfi has spoken on 16 earnings calls and 3 other investor events across 1 company, most recently for Kymera Therapeutics, Inc. on September 15, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Kymera Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Kymera Therapeutics, Inc. (KYMR) $693,000 $8,545,609
2024 Kymera Therapeutics, Inc. (KYMR) $670,000 $15,433,147
2023 Kymera Therapeutics, Inc. (KYMR) $640,000 $9,670,542
2022 Kymera Therapeutics, Inc. (KYMR) $600,000 $6,926,645
2021 Kymera Therapeutics, Inc. (KYMR) $570,582 $11,573,374
2020 Kymera Therapeutics, Inc. (KYMR) $453,619 $3,678,001

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 7 earlier activities